He'll ride to raise money for cancer research and treatment in honor of fellow pitcher Tim Wakefield, who died in 2023 of ...

Lung cancer remains the leading cause of cancer mortality worldwide. Immunotherapy has recently emerged as a promising therapeutic strategy both for ...

Martin, who died this week of colon cancer at the age of 30, said his five-year battle began with a single symptom.

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

BE is the only known precursor to esophageal cancer. The condition is caused by prolonged exposure of the esophagus to ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths ...

Recent advances in RAS-targeted therapies revolutionize treatment for gastrointestinal cancers, promising improved outcomes ...

'Biomarkers' may help to improve detection and treatment of gastrointestinal diseases such as gastric cancer, colorectal cancer, and inflammatory bowel disease.

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery and other types of more invasive treatment to cure their disease.

Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment approaches. Gastrointestinal Stromal Tumors: GISTs Diagnosis & Treatment - Los ...

Radiation therapy advancements, including SBRT and proton therapy, have improved precision and reduced side effects for GI cancer patients, enhancing their quality of life. Personalized treatment ...